Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,761 | -61,389 | -45,655 | -30,362 | -16,055 |
| Depreciation Amortization | 1,029 | 2,110 | 1,342 | 863 | 419 |
| Accounts receivable | 679 | -20 | 102 | -34 | 628 |
| Accounts payable and accrued liabilities | 1,558 | 1,838 | 1,691 | 909 | -1,575 |
| Other Working Capital | -938 | -4,693 | -4,117 | -6,155 | -4,879 |
| Other Operating Activity | 3,321 | 5,812 | 3,990 | 3,009 | 2,808 |
| Operating Cash Flow | $-17,112 | $-56,342 | $-42,647 | $-31,770 | $-18,654 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,049 | -39,393 | -30,402 | -29,715 | -9,681 |
| PPE Investments | -1,418 | -8,423 | -7,278 | -6,653 | -2,653 |
| Investing Cash Flow | $15,631 | $-47,816 | $-37,680 | $-36,368 | $-12,334 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,181 | 19,189 | N/A | N/A |
| Common Stock Issued | 124 | 45,154 | 44,493 | 44,309 | 43,777 |
| Other Financing Activity | -669 | -493 | -493 | -493 | -493 |
| Financing Cash Flow | $-545 | $63,842 | $63,189 | $43,816 | $43,284 |
| Beginning Cash Position | 15,986 | 56,302 | 56,302 | 56,302 | 56,302 |
| End Cash Position | 13,960 | 15,986 | 39,164 | 31,980 | 68,598 |
| Net Cash Flow | $-2,026 | $-40,316 | $-17,138 | $-24,322 | $12,296 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,112 | -56,342 | -42,647 | -31,770 | -18,654 |
| Capital Expenditure | -1,418 | -8,428 | -7,281 | -6,656 | -2,656 |
| Free Cash Flow | -18,530 | -64,770 | -49,928 | -38,426 | -21,310 |